Sangamo BioSciences, Inc. - Product Pipeline Review - 2016 - Global Markets Direct - Market Research

Sangamo BioSciences, Inc. - Product Pipeline Review - 2016

Sangamo BioSciences, Inc. - Product Pipeline Review - 2016 - Global Markets Direct - Market Research
Sangamo BioSciences, Inc. - Product Pipeline Review - 2016
Published Jun 08, 2016
55 pages — Published Jun 08, 2016
Price US$ 1,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Global Markets Directs, Sangamo BioSciences, Inc. - Product Pipeline Review - 2016, provides an overview of the Sangamo BioSciences, Inc.s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Sangamo BioSciences, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Sangamo BioSciences, Inc.
- The report provides overview of Sangamo BioSciences, Inc. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Sangamo BioSciences, Inc.s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Sangamo BioSciences, Inc.s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Sangamo BioSciences, Inc.s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Sangamo BioSciences, Inc.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Sangamo BioSciences, Inc.s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

  
Source:
Document ID
GMDHC08065CDB
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents24
  List of Tables51
  List of Figures51
Sangamo BioSciences, Inc. Snapshot61
  Sangamo BioSciences, Inc. Overview61
  Key Information61
  Key Facts61
Sangamo BioSciences, Inc. Research and Development Overview73
  Key Therapeutic Areas73
Sangamo BioSciences, Inc. Pipeline Review102
  Pipeline Products by Stage of Development101
  Pipeline Products Monotherapy111
Sangamo BioSciences, Inc. Pipeline Products Glance125
  Sangamo BioSciences, Inc. Clinical Stage Pipeline Products121
    Phase II Products/Combination Treatment Modalities121
    Phase I Products/Combination Treatment Modalities131
  Sangamo BioSciences, Inc. Early Stage Pipeline Products141
    IND/CTA Filed Products/Combination Treatment Modalities141
    Preclinical Products/Combination Treatment Modalities151
    Discovery Products/Combination Treatment Modalities161
Sangamo BioSciences, Inc. Drug Profiles1717
  SB-728T171
    Product Description171
    Mechanism of Action171
    R&D Progress172
  SB-728HSPC191
    Product Description191
    Mechanism of Action191
    R&D Progress191
  SB-FIX201
    Product Description201
    Mechanism of Action201
    R&D Progress202
  SB-318221
    Product Description221
    Mechanism of Action221
    R&D Progress221
  Stem Cell Therapy for Beta Thalassemia231
    Product Description231
    Mechanism of Action231
    R&D Progress231
  Gene Therapy for Sickle Cell Disease241
    Product Description241
    Mechanism of Action241
    R&D Progress241
  Gene Therapy for X-Linked SCID251
    Product Description251
    Mechanism of Action251
    R&D Progress251
  Gene Therapy to Activate Alpha-1 Antitrypsin for Alpha-Antitrypsin Deficiency261
    Product Description261
    Mechanism of Action261
    R&D Progress261
  Gene Therapy to Active Pulmonary Surfactant-Associated Protein B for Lung Diseases271
    Product Description271
    Mechanism of Action271
    R&D Progress271
  Gene Therapy to Inhibit Huntingtin Protein for Huntington s Disease281
    Product Description281
    Mechanism of Action281
    R&D Progress281
  SB-913291
    Product Description291
    Mechanism of Action291
    R&D Progress291
  SB-FVIII301
    Product Description301
    Mechanism of Action301
    R&D Progress301
  SBLSD-3311
    Product Description311
    Mechanism of Action311
    R&D Progress311
  SBLSD-4321
    Product Description321
    Mechanism of Action321
    R&D Progress321
  Gene Therapy for Monogenic Diseases331
    Product Description331
    Mechanism of Action331
    R&D Progress331
Sangamo BioSciences, Inc. Pipeline Analysis344
  Sangamo BioSciences, Inc. Pipeline Products by Target341
  Sangamo BioSciences, Inc. Pipeline Products by Route of Administration351
  Sangamo BioSciences, Inc. Pipeline Products by Molecule Type361
  Sangamo BioSciences, Inc. Pipeline Products by Mechanism of Action371
Sangamo BioSciences, Inc. Recent Pipeline Updates3811
Sangamo BioSciences, Inc. Dormant Projects491
Sangamo BioSciences, Inc. Discontinued Pipeline Products501
  Discontinued Pipeline Product Profiles501
    CERE-110501
    CERE-120501
    SB-509501
Sangamo BioSciences, Inc. Company Statement512
Sangamo BioSciences, Inc. Locations And Subsidiaries531
  Head Office531
  Other Locations &Subsidiaries531
Appendix542
  Methodology541
  Coverage541
  Secondary Research541
  Primary Research541
  Expert Panel Validation541
  Contact Us541
  Disclaimer551

Table Of Contents

Global Markets Direct - Market Research—Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

About the Author


Cite this Report

  
MLA:
Global Markets Direct - Market Research. "Sangamo BioSciences, Inc. - Product Pipeline Review - 2016" Jun 08, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Sangamo-BioSciences-Inc-Product-Pipeline-Review-2016-2088-15934>
  
APA:
Global Markets Direct - Market Research. (2016). Sangamo BioSciences, Inc. - Product Pipeline Review - 2016 Jun 08, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Sangamo-BioSciences-Inc-Product-Pipeline-Review-2016-2088-15934>
  
US$ 1,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.